SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Overview Fund Activity
Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

27 hedge funds and large institutions have $71.9M invested in Sierra Oncology, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+1
Holders Change %
+3.85%
% of All Funds
0.55%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
3
Increased
6
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
Ikarian Capital
Texas
$3.35M
2
BFM
Boothbay Fund Management
New York
$405K
3
BCM
Bridgeway Capital Management
Texas
$573K
4
WG
Winton Group
United Kingdom
$111K
5
Morgan Stanley
Morgan Stanley
New York
$109K

Top Sellers

1
VA
VR Adviser
New York
$0
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
$23K
3
MP
Mangrove Partners
Connecticut
$4.42M
4
TRCT
Tower Research Capital (TRC)
New York
$4K
5
PAG
Private Advisor Group
New Jersey
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RE
26
RBC Europe
United Kingdom
$256 – – –
VA
27
VR Adviser
New York
– -$4.59M -378,888 Closed
PAG
28
Private Advisor Group
New Jersey
– -$1K -100 Closed
1
2